Montelukast sodium powder Raw Materials CAS 151767-02-1
Montelukast sodium powder Raw Materials CAS 151767-02-1
Montelukast sodium powder Raw Materials CAS 151767-02-1
Montelukast sodium powder Raw Materials CAS 151767-02-1
Home > Organic Raw Materials

Montelukast sodium powder Raw Materials CAS 151767-02-1

Related Attributes


Product details

Uses and synthesis of Montelukast sodium powder

Montelukast sodium powder. Common dosage forms are tablets, granules, chewable tablets. For the prevention and long-term treatment of asthma. Montelukast sodium is an orally effective selective leukotriene receptor antagonist, which can specifically inhibit cysteylleukotriene receptors, and was successfully developed by Merck in Germany and launched in Canada, Finland and Mexico in 1997. Montelukast sodium is suitable for the prevention and long-term treatment of asthma in adults and children, including the prevention of daytime and nighttime asthma symptoms, the treatment of aspirin-sensitive asthma patients, and the prevention of exercise-induced bronchoconstriction, Montelukast sodium may also be used to relieve symptoms of seasonal allergic rhinitis in patients 15 years of age and older who have not responded to or are intolerant to other treatments.

Montelukast sodium powder

Applications/Functions of Montelukast sodium powder

Montelukast sodium powder

Physicochemical Property of Montelukast sodium powder

Montelukast sodium


Why choose us?

factory

HRK Factory

HRK Factory

About Shipping

shipping

Prev: Minocycline hydrochloride powder Raw Materials CAS 13614-98-7 Next: Nitrofurantoin powder Raw Materials CAS 67-20-9

Pharmaceutical Intermediate manufacturers

sales08@interlgroup.com

©2023 Xi'an Henrikang Biotech Co., Ltd.,

HomeHome
EmailE-mail
ProductBooking